AUTOLOGOUS HEAT SHOCK ROTEIN VACCINE FOR RECURRENT GLIOMA: UPDATED RESULTS OF A PHASE I CLINICAL TRIAL

被引：0

作者：

Parsa, Andrew ^{[1
]}

Crane, Courtney ^{[1
]}

Burkowski, Nicholas ^{[1
]}

Cachola, Kristine ^{[1
]}

Chang, Susan ^{[1
]}

Fedoroff, Anne

Kivette, Valerie

Mcdermott, Michael ^{[1
]}

Murray, Joseph ^{[1
]}

Page, Margaretta ^{[1
]}

Prados, Michael ^{[1
]}

Rabbitt, Jane ^{[1
]}

Berger, Mitchel ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

NEURO-ONCOLOGY | 2008年 / 10卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：841 / 841

页数：1

共 50 条

[1] Autologous heat shock protein vaccine for recurrent glioma: Results of a phase I clinical trial
Parsa, Andrew T.
Brannon, Courtney
Butowski, Nicholas
Cachola, Kristine
Chang, Susan
Federoff, Anne
Kivette, Valerie
McDermott, Michael W.
Murray, Joseph
Page, Margaretta
Prados, Michael D.
Rabbit, Jane
Berger, Mitchel S.
JOURNAL OF NEUROSURGERY, 2007, 106 (04) : A742 - A742
[2] Autologous heat shock protein vaccine (HSPPC-96) for patients with recurrent glioblastoma (GBM): Results of a phase II multicenter clinical trial with immunological assessments.
Parsa, A.
Crane, C.
Han, S.
Kivett, V.
Fedoroff, A.
Butowski, N. A.
Chang, S. M.
Clarke, J. L.
Berger, M. S.
McDermott, M.
Aghi, M.
Yanes, C.
Prados, M.
Sloan, A. E.
Bruce, J. N.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[3] Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial
Yamanaka, Ryuya
Homma, Junpei
Yajima, Naoki
Sano, Masakazu
Takahashi, Masuhiro
MOLECULAR THERAPY, 2006, 13 : S106 - S106
[4] Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial
Yamanaka, R
Homma, J
Yajima, N
Tsuchiya, N
Sano, M
Kobayashi, T
Yoshida, S
Abe, T
Narita, M
Takahashi, M
Tanaka, R
CLINICAL CANCER RESEARCH, 2005, 11 (11) : 4160 - 4167
[5] Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
Kikuchi, T
Akasaki, Y
Irie, M
Homma, S
Abe, T
Ohno, T
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001, 50 (07) : 337 - 344
[6] Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
Tetsuro Kikuchi
Yasuharu Akasaki
Masaki Irie
Sadamu Homma
Toshiaki Abe
Tsuneya Ohno
Cancer Immunology, Immunotherapy, 2001, 50 : 337 - 344
[7] Results of a phase IIB actively controlled clinical trial in patients with recurrent malignant glioma
Bogdahn, U.
Parfenov, V. E.
Oliushine, V.
Kunst, M.
Mahaparra, A.
Sastry, K.
Venkataramana, N. K.
Jachimczak, P.
Hau, P.
Schlingensiepen, K.
NEURO-ONCOLOGY, 2006, 8 (04) : 305 - 305
[8] Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial
Shimizu, Yasuhiro
Yoshikawa, Toshiaki
Kojima, Takashi
Shoda, Kayoko
Nosaka, Kazuto
Mizuno, Shoichi
Wada, Satoshi
Fujimoto, Yuki
Sasada, Tetsuro
Kohashi, Kenichi
Bando, Hideaki
Endo, Itaru
Nakatsura, Tetsuya
CANCER SCIENCE, 2019, 110 (10) : 3049 - 3060
[9] Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma:: Biological and clinical results
Lang, FF
Bruner, JM
Fuller, GN
Aldape, K
Prados, MD
Chang, S
Berger, MS
McDermott, MW
Kunwar, SM
Junck, LR
Chandler, W
Zwiebel, JA
Kaplan, RS
Yung, WKA
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) : 2508 - 2518
[10] Non-Invasive Multiplex ELISA Identifies Clinical Responders to Autologous Dendritic Cell Vaccine for Recurrent High-Grade Glioma in Phase 1 Clinical Trial
Chandar, Jay
Kushnirsky, Marina
Suter, Robert
Koru-Sengul, Tulay
Marrero, Alain Fernandez
Tejera, Dalissa
Walters, Winston
Seetharam, Deepa
Liendo, Michelle
Khan, Aisha
Ayad, Nagi
Ivan, Michael E.
Komotar, Ricardo Jorge
Shah, Ashish H.
de la Fuente, Macarena
NEUROSURGERY, 2025, 71 : 242 - 242

← 1 2 3 4 5 →